Literature DB >> 31228814

Predictive value of post-operative neutrophil/lymphocyte count ratio for surgical site infection in patients following posterior lumbar spinal surgery.

Chao-Jun Shen1, Tao Miao1, Zhang-Fu Wang1, Zhen-Fa Li2, Ling-Qin Huang1, Ting-Ting Chen1, Wei-Hua Yan3.   

Abstract

OBJECTIVE: Surgical site infection (SSI) is a common complication in patients following posterior lumbar spinal surgery. Various laboratory data such as laboratory parameters derived neutrophil/lymphocyte count ratio (NLR), have been applied for the prediction of SSI, but more studies are necessary to evaluate the significance of these indicators. Here, our study aims to investigate the predictive value of total white blood cells (WBCs), count and percentages of neutrophils and leukocytes, NLR, and C-reactive protein (CRP) for surgical site infection (SSI) in patients after posterior lumbar spinal surgery.
METHODS: A total of 293 patients who underwent posterior lumbar spinal surgery were enrolled in this study. Each patient's medical history was retrospectively reviewed, and patients were divided into the deep SSI group (n = 13) and the non-SSI group (n = 280). Laboratory data including total WBC, count and percentages of neutrophils and leukocytes, NLR at 1 week before the operation and the 4 and 7 days post-operation, and CRP at 4 and 7 days post-operation were analysed between the SSI and non-SSI groups. Moreover, predictive power and cut-off of NLR for SSI were determined by receiver operating characteristic curve (ROC) results.
RESULTS: Data revealed that the medians of NLR were markedly increased in the SSI group as compared to that in non-SSI group at 4 days (p = 0.011) and 7 days (p = 0.047) post-operation. Moreover, the neutrophil percentage was also dramatically increased in the SSI group at both 4 and 7 days post-operation (p = 0.010 and p = 0.030) respectively compared to the non-SSI group. However, no significant difference was observed between the groups 1 week before the operation. ROC results showed that NLR at 4 days (cut-off >5.19; sensitivity: 61.5%; specificity: 77.6%; AUC = 0.708) and 7 days (cut-off >3.85; sensitivity: 69.2%; specificity: 62.7%; AUC = 0.663) post-operation could significantly discriminate the SSI and non-SSI groups. Logistic regression analysis showed that NLR at both post-operative time points (OR = 1.218; p = 0.003 and OR = 1.296; p = 0.048) could be valuable predictors for SSI.
CONCLUSION: NLR at 4 and 7 days post-operation are valuable laboratory predictors for SSI in patients with posterior lumbar spinal surgery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Lumbar; Surgery; Surgical site infection; White blood cell; White blood cell subsets

Mesh:

Substances:

Year:  2019        PMID: 31228814     DOI: 10.1016/j.intimp.2019.105705

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

1.  Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting postoperative complications after pancreaticoduodenectomy.

Authors:  Haoquan Huang; Chengli Wang; Fengtao Ji; Zhixiao Han; Hui Xu; Minghui Cao
Journal:  Gland Surg       Date:  2021-03

2.  Pre-surgical peripheral blood inflammation markers predict surgical site infection following mesh repair of groin hernia.

Authors:  Yeye Zhuo; Juntian Chen; Qian Zhang; Xinxin Li
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

3.  Preoperative lymphocyte percentage and neutrophil-lymphocyte ratio are useful predictors of 30-day postoperative complications after lumbar fusion.

Authors:  Temidayo Osunronbi; Balint Borbas; Hiba Lusta; Agbolahan Sofela; Himanshu Sharma
Journal:  Surg Neurol Int       Date:  2022-04-15

4.  Changes in Invasiveness and Latent Infection Rate Associated with Switching the Approach in Total Hip Replacement.

Authors:  Hiroaki Kijima; Kenji Tateda; Shin Yamada; Satoshi Nagoya; Masashi Fujii; Ima Kosukegawa; Tetsuya Kawano; Naohisa Miyakoshi; Toshihiko Yamashita; Yoichi Shimada
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.